China Wantian Holdings (01854.HK): Enters Strategic Cooperation Framework Agreement with Hengyang Jisuo to Foray into Exoskeleton Robot Sector

NewTimeSpace · 2026/07/19 22:02 · By Boyuan Chen

NewTimeSpace News: China Wantian Holdings announced on 19 July that Wantian Artificial Intelligence Technology, its indirectly wholly-owned subsidiary, has signed a strategic cooperation framework agreement with Hengyang Jisuo Medical Technology to cooperate on AI-powered exoskeleton robot products and smart medical solutions.

NewTimeSpace News: On 19 July 2026, China Wantian Holdings (01854.HK) issued an announcement that its indirectly wholly-owned subsidiary entered into a strategic cooperation framework agreement with Hengyang Jisuo. The cooperation covers product supply and technical collaboration, market and brand cooperation, implementation of application scenarios and exploration of business models.

Hengyang Jisuo is a wholly-owned subsidiary of Hunan Jisuo Medical. It specializes in the research, development, production and sales of medical rehabilitation and sports-assisting exoskeleton robots, and holds technologies including lightweight exoskeleton design and AI gait algorithms.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

China Wantian Holdings 01854.HK